middl
east
respiratori
syndrom
coronaviru
merscov
first
discov
late
gone
caus
infect
death
current
approv
therapeut
vaccin
merscov
merscov
spike
protein
respons
receptor
bind
virion
entri
cell
immunodomin
induc
neutral
antibodi
vivo
make
protein
ideal
target
antimerscov
vaccin
studi
demonstr
protect
induc
vaccin
recombin
merscov
nanoparticl
vaccin
adjuv
combin
mice
merscov
nanoparticl
vaccin
produc
high
titer
anti
neutral
antibodi
protect
mice
merscov
infect
vivo
middl
east
respiratori
syndrom
coronaviru
merscov
highli
pathogen
respiratori
viru
first
identifi
kingdom
saudi
arabia
sinc
discoveri
merscov
caus
confirm
case
death
across
countri
http
wwwwhoint
current
approv
vaccin
treatment
merscov
merscov
spike
protein
virion
surfac
main
attach
factor
virion
entri
bind
dipeptidyl
peptidas
iv
host
cell
merscov
prime
target
vaccin
strategi
review
previous
report
protein
vaccin
candid
abl
induc
high
level
antimerscov
neutral
antibodi
mice
major
problem
merscov
treatment
vaccin
test
vivo
mice
suscept
merscov
infect
mous
function
merscov
receptor
merscov
bind
inhibit
glycosyl
two
residu
hypothes
physic
inhibit
bind
merscov
therefor
mous
model
develop
focus
human
mice
made
suscept
merscov
infect
adenoviru
transduct
human
h
lung
mice
though
express
mice
display
mild
clinic
symptom
merscov
infect
robust
merscov
replic
lung
mice
make
use
test
treatment
vaccin
block
merscov
replic
lung
studi
vaccin
mice
merscov
nanoparticl
show
protect
merscov
infect
vivo
jordan
strain
merscov
kindli
provid
dr
kanta
subbarao
nih
bethesda
md
dr
gabriel
defang
cairo
eg
dr
michael
cooper
afhsc
dr
emad
mohereb
stock
merscov
jordan
grown
quantifi
use
vero
cell
atcc
describ
previous
experi
live
merscov
jordan
perform
biosafeti
level
condit
univers
maryland
school
medicin
adenoviru
express
obtain
gene
transfer
vector
core
univers
iowa
balbc
mice
obtain
charl
river
laboratori
mous
experi
perform
univers
maryland
school
medicin
accord
protocol
approv
local
institut
anim
care
use
committe
iacuc
balbc
mice
week
age
intramuscularli
vaccin
either
pb
merscov
nanoparticl
without
adjuv
novavax
ab
uppsala
sweden
previous
describ
mice
vaccin
day
day
postiniti
vaccin
blood
collect
retroorbit
bleed
merscov
sspecif
antibodi
mous
sera
evalu
elisa
describ
previous
except
maxisorp
microtit
plate
thermo
scientif
coat
purifi
merscov
protein
horseradish
peroxidas
conjug
goat
antimous
igg
southern
biotech
use
secondari
antibodi
merscov
neutral
assay
use
day
sera
vaccin
mice
perform
describ
previous
day
postiniti
vaccin
vaccin
mice
transduc
describ
previous
mice
intranas
inocul
pfu
merscov
jordan
describ
previous
experi
mice
weigh
day
merscov
infect
everi
subsequ
day
day
postinfect
mice
sacrif
lung
harvest
previous
describ
lung
merscov
titer
level
merscov
genom
rna
leader
contain
mrna
determin
previous
describ
rel
rna
level
quantifi
use
method
compar
pb
vaccin
control
data
analys
use
anova
bonnferoni
posttest
graphpad
prism
statist
signific
achiev
p
sera
collect
day
postiniti
vaccin
analyz
antimerscov
antibodi
titer
elisa
figur
expect
pb
vaccin
mice
detect
anti
antibodi
mice
nonadjuv
mer
nanoparticl
group
measur
antimerscov
antibodi
respons
statist
signific
compar
pb
vaccin
control
sera
mice
vaccin
adjuv
combin
mer
nanoparticl
demonstr
significantli
higher
anti
titer
exampl
p
merscov
nanoparticl
compar
pb
vaccin
control
appar
dose
depend
increas
data
demonstr
merscov
nanoparticl
along
adjuv
produc
high
titer
antimerscov
antibodi
vaccin
mice
neutral
antibodi
level
sera
day
postiniti
vaccin
assess
use
live
merscov
neutral
assay
figur
sera
mice
vaccin
mer
nanoparticl
alon
show
signific
neutral
merscov
p
compar
pb
vaccin
control
sera
pb
vaccin
mice
show
antimerscov
neutral
activ
probabl
result
nonspecif
antivir
activ
sera
mice
vaccin
adjuv
combin
mer
nanoparticl
show
significantli
higher
neutral
antibodi
titer
compar
pb
vaccin
control
p
also
correspond
merscov
nanoparticl
alon
exampl
p
merscov
nanoparticl
except
dose
p
mice
show
low
level
antibodi
merscov
nanoparticl
plu
matrix
group
within
adjuv
group
signific
differ
p
merscov
neutral
antibodi
level
mice
vaccin
mer
nanoparticl
data
suggest
mice
vaccin
mer
nanoparticl
combin
produc
merscov
neutral
antibodi
util
merscov
model
adenoviru
express
use
transduc
mice
assess
merscov
replic
vaccin
mice
figur
expect
weight
loss
observ
infect
figur
achiev
effici
replic
merscov
pb
vaccin
mice
demonstr
merscov
titer
figur
merscov
leader
mrna
express
figur
genom
rna
express
figur
mice
vaccin
merscov
nanoparticl
show
statist
signific
p
reduct
merscov
titer
figur
merscov
genom
rna
figur
merscov
mrna
figur
howev
case
detect
merscov
lung
vaccin
mice
mice
vaccin
combin
merscov
nanoparticl
except
two
mice
group
merscov
titer
figur
merscov
genom
rna
figur
merscov
mrna
figur
reduc
baselin
level
p
suggest
merscov
replic
complet
block
lung
vaccin
mice
data
suggest
merscov
nanoparticl
vaccin
combin
matrix
adjuv
abl
block
merscov
replic
lung
vaccin
mice
highli
pathogen
coronavirus
caus
signific
problem
public
health
emerg
sarscov
merscov
current
approv
vaccin
treatment
merscov
howev
vaccin
drug
candid
shown
effect
vitro
andor
vivo
anim
model
protein
merscov
prime
target
vaccin
strategi
main
attach
factor
express
virion
surfac
therefor
variou
vaccin
strategi
test
elicit
anti
respons
previous
describ
merscov
nanoparticl
abl
induc
strong
neutral
antibodi
respons
merscov
howev
test
vivo
model
merscov
infect
mice
suscept
merscov
infect
function
receptor
merscov
suscept
merscov
bind
correl
glycosyl
critic
residu
therefor
option
make
mice
suscept
merscov
express
lung
mice
use
adenoviru
vector
model
robust
replic
merscov
lung
transduc
mice
detect
plaqu
assay
merscov
rna
express
therefor
use
model
test
merscov
nanoparticl
vaccin
vivo
agreement
previou
studi
found
mice
vaccin
merscov
nanoparticl
develop
merscov
neutral
antibodi
respons
target
merscov
neutral
assay
see
low
level
nonspecif
neutral
activ
pb
vaccin
mice
howev
adjuv
merscov
nanoparticl
vaccin
mice
significantli
higher
neutral
activ
furthermor
adjuv
enhanc
antimerscov
neutral
antibodi
respons
vaccin
mice
final
demonstr
mice
vaccin
merscov
nanoparticl
abl
effici
complet
block
merscov
replic
lung
merscov
nanoparticl
formul
prime
candid
develop
use
camel
human
